| PICTORIAL ESSAY |
|
| Year : 2017 | Volume
: 32
| Issue : 4 | Page : 316-321 |
|
|
18F-fluorodeoxyglucose-positron emission tomography/computed tomography in tuberculosis: Spectrum of manifestations
Krishan Kant Agarwal1, Abhishek Behera1, Rakesh Kumar2, Chandrasekhar Bal1
1 Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India
2 Department of Nuclear Medicine, Division of Diagnostic Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India
Correspondence Address:
Rakesh Kumar
Department of Nuclear Medicine, Division of Diagnostic Nuclear Medicine, All India Institute of Medical Sciences, New Delhi - 110 029
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijnm.IJNM_29_17
|
|
|
The objective of this article is to provide an illustrative tutorial highlighting the utility of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography (18F-FDG-PET/CT) imaging to detect spectrum of manifestations in patients with tuberculosis (TB). FDG-PET/CT is a powerful tool for early diagnosis, measuring the extent of disease (staging), and consequently for evaluation of response to therapy in patients with TB.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
